Omeprazolo Aristo Pharma (Omeprazole)

Omeprazole is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related disorders:

• Gastro‑oesophageal reflux disease (GERD): provides relief of heartburn and promotes healing of erosive esophagitis.
• Peptic ulcer disease: supports ulcer healing and reduces recurrence risk.
• Zollinger‑Ellison syndrome: controls gastric acid hypersecretion associated with gastrin‑producing tumors.
• Helicobacter pylori eradication regimens: used as part of combination therapy to improve eradication rates.
• NSAID‑associated ulcer prevention: lowers the risk of ulcer development in patients requiring long‑term NSAID therapy.

• Omeprazole irreversibly binds to the H+/K+‑ATPase enzyme (the gastric proton pump) on the secretory surface of parietal cells, inhibiting the final step of acid secretion. By blocking this pump, it markedly reduces gastric acidity, allowing mucosal healing and symptom relief in acid‑related disorders.

Omeprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects

• Headache: mild to moderate intensity.
• Diarrhea: usually self‑limiting.
• Nausea or vomiting: transient gastrointestinal upset.
• Abdominal pain or flatulence: mild discomfort.
• Constipation: occasional bowel habit changes.
• Dry mouth: reduced salivation.

Serious or Rare Side Effects

• Severe allergic reactions: rash, itching, swelling, or anaphylaxis.
• Clostridioides difficile infection: persistent diarrhea with abdominal pain.
• Low magnesium levels (hypomagnesemia): muscle cramps, irregular heartbeat.
• Bone fractures: increased risk with long‑term use.
• Acute interstitial nephritis: kidney inflammation presenting with fever and rash.
• Liver enzyme elevations: signs of hepatic dysfunction.

Before starting Omeprazolo Aristo Pharma, consider the following precautions:

• Assess renal function: dose adjustment may be needed in severe impairment.
• Evaluate hepatic status: use with caution in patients with liver disease.
• Review long‑term use: monitor for bone density loss and magnesium levels.
• Pregnancy and lactation: discuss risks and benefits with a healthcare professional.
• Drug interactions: check concomitant medications for potential interactions.
• Store below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Omeprazole can affect the plasma concentrations of several co‑administered drugs.

Major Interactions (Avoid)

• Clopidogrel: reduced antiplatelet effect, increasing cardiovascular risk.
• Atazanavir and other protease inhibitors: markedly decreased absorption, compromising antiviral efficacy.
• Warfarin: enhanced anticoagulant effect, raising bleeding risk.

Moderate Interactions (Monitor Closely)

• Digoxin: increased serum levels, requiring dose adjustment.
• Methotrexate: elevated concentrations, especially at high doses.
• Phenytoin: reduced plasma levels, potentially decreasing seizure control.